Home > Insider Trading > Filing (0001104659-21-028944)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1772028	Scopus Biopharma Inc.	SCPS	Pharmaceutical Preparations (2834)	821248020

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1821615	J Robert Gibson	C/O Scopus Biopharma Inc. 420 Lexington Avenue, Suite 300 New York NY 10170	Vice Chairman	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, Par Value $0.001	Acquisiton	2021-02-24	150	$9.46	150	No	4	P	Direct
Common Stock, Par Value $0.001	Acquisiton	2021-02-25	150	$9.29	300	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Direct

Footnotes

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.41 to $9.65 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.22 to $9.49 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (2) to this Form 4.